![](/img/cover-not-exists.png)
Drug survival, discontinuation rates, and safety profile of secukinumab in realâworld patients: a 152âweek, multicenter, retrospective study
RuizâVillaverde, Ricardo, RodriguezâFernandezâFreire, Lourdes, GalánâGutierrez, Manuel, ArmarioâHIta, Jose C., MartinezâPilar, LeandroLanguage:
english
Journal:
International Journal of Dermatology
DOI:
10.1111/ijd.14819
Date:
March, 2020
File:
PDF, 528 KB
english, 2020